VIKAS KUNDRA to Receptors, Vascular Endothelial Growth Factor
This is a "connection" page, showing publications VIKAS KUNDRA has written about Receptors, Vascular Endothelial Growth Factor.
Connection Strength
0.022
-
Phase 1-2 study of docetaxel plus aflibercept in patients with recurrent ovarian, primary peritoneal, or fallopian tube cancer. Lancet Oncol. 2011 Nov; 12(12):1109-17.
Score: 0.022